Skip to main content
SpringerLink
Log in

Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Lysosome associated protein transmembrane 4beta (LAPTM4B) contribute to the risk of numerous cancers. The present study focused on the possible association between LAPTM4B polymorphism and the risk of breast cancer (BC) in an Iranian population in southeast Iran. This case control study includes 311 BC patients and 225 healthy women. Genomic DNA was extracted from the whole blood by salting out method and LAPTM4B genotype was investigated using polymerase chain reaction. Our findings showed that LAPTM4B genotype was not associated with the risk of BC in any inheritance model tested. The minor allele frequency in case and control group was 0.297 and 0.278, respectively. The minor allele (LAPTM4B*2) was not associated with BC risk in comparison with LAPTM4B*1 allele (odds ratio 1.10, 95 % confidence intervals 0.84–1.44, p = 0.495). Moreover, LAPTM4B polymorphism was not associated with clinical and pathological characteristics in the patient group. In conclusion, the findings of our study suggested that the polymorphism of LAPTM4B gene was not associated with susceptibility to BC and clinicopathological characteristics in an Iranian population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.

    Article  PubMed  Google Scholar 

  2. Song M, Lee KM, Kang D. Breast cancer prevention based on gene-environment interaction. Mol Carcinog. 2011;50(4):280–90.

    Article  CAS  PubMed  Google Scholar 

  3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70.

    Article  CAS  PubMed  Google Scholar 

  4. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev. 1996;76(1):69–125.

    CAS  PubMed  Google Scholar 

  5. Yu JC, Ding SL, Chang CH, et al. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. Carcinogenesis. 2009;30(9):1562–70.

    Article  CAS  PubMed  Google Scholar 

  6. Hashemi M, Fazaeli A, Ghavami S, et al. Functional Polymorphisms of FAS and FASL Gene and Risk of Breast Cancer–Pilot Study of 134 Cases. PLoS ONE. 2013;8(1):e53075.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Mo C, Lu Y, Deng Y, et al. LAPTM4B polymorphism increases susceptibility to multiple cancers in Chinese populations: a meta-analysis. BMC Genet. 2014;15(1):48.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Omrani M, Hashemi M, Eskanadri-Nasab E, et al. Hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population. Biomark Med. 2014;8(2):257–65.

    Article  Google Scholar 

  9. Eskandari-Nasab E, Hashemi M, Rezaei H, et al. Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer. Mol Biol Rep. 2012;39(12):10531–9.

    Article  CAS  PubMed  Google Scholar 

  10. Liu J, Zhou R, Zhang N, et al. Biological function of a novel gene overexpressed in human hepatocellular carcinoma. Chin Med J (Engl). 2000;113(10):881–5.

    CAS  PubMed  Google Scholar 

  11. Shao GZ, Zhou RL, Zhang QY, et al. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. Oncogene. 2003;22(32):5060–9.

    Article  CAS  PubMed  Google Scholar 

  12. Vergarajauregui S, Martina JA, Puertollano R. LAPTMs regulate lysosomal function and interact with mucolipin 1: new clues for understanding mucolipidosis type IV. J Cell Sci. 2011;124(Pt 3):459–68.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Kasper G, Vogel A, Klaman I, et al. The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression. Cancer Lett. 2005;224(1):93–103.

    Article  CAS  PubMed  Google Scholar 

  14. Yang H, Xiong F, Qi R, et al. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma. J Surg Oncol. 2010;101(5):363–9.

    Article  CAS  PubMed  Google Scholar 

  15. Zhang G, Liang Y, Huang Y, et al. Elevated lysosome-associated protein transmembrane-4beta-35 is an independent prognostic marker in pancreatic carcinoma. J Int Med Res. 2012;40(4):1275–83.

    Article  CAS  PubMed  Google Scholar 

  16. Zhou L, He XD, Cui QC, et al. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma. Cancer Lett. 2008;264(2):209–17.

    Article  CAS  PubMed  Google Scholar 

  17. Meng F, Li H, Zhou R, et al. LAPTM4B gene polymorphism and endometrial carcinoma risk and prognosis. Biomarkers. 2013;18(2):136–43.

    Article  CAS  PubMed  Google Scholar 

  18. Yang Y, Yang H, McNutt MA, et al. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma. Oncol Rep. 2008;20(5):1077–83.

    PubMed  Google Scholar 

  19. Xiao M, Jia S, Wang H, et al. Overexpression of LAPTM4B: an independent prognostic marker in breast cancer. J Cancer Res Clin Oncol. 2013.

  20. Zhang H, Wei Q, Liu R, et al. Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer. PLoS ONE. 2014;9(3):e91069.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Fan M, Liu Y, Zhou R, et al. Association of LAPTM4B gene polymorphism with breast cancer susceptibility. Cancer Epidemiol. 2012;36(4):364–8.

    Article  CAS  PubMed  Google Scholar 

  22. Li X, Kong X, Chen X, et al. LAPTM4B allele *2 is associated with breast cancer susceptibility and prognosis. PLoS ONE. 2012;7(9):e44916.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Yang H, Zhai G, Ji X, et al. Correlation of LAPTM4B polymorphisms with gallbladder carcinoma susceptibility in Chinese patients. Med Oncol. 2012;29(4):2809–13.

    Article  CAS  PubMed  Google Scholar 

  24. Li Y, Iglehart JD, Richardson AL, et al. The amplified cancer gene LAPTM4B promotes tumor growth and tolerance to stress through the induction of autophagy. Autophagy. 2012;8(2):273–4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Liu Y, Zhang QY, Qian N, et al. Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer. Ann Oncol. 2007;18(2):311–6.

    Article  CAS  PubMed  Google Scholar 

  26. Cheng XJ, Xu W, Zhang QY, et al. Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers. Ann Oncol. 2008;19(3):527–32.

    Article  PubMed  Google Scholar 

  27. Xu Y, Liu Y, Zhou R, et al. LAPTM4B polymorphisms is associated with ovarian cancer susceptibility and its prognosis. Jpn J Clin Oncol. 2012;42(5):413–9.

    Article  PubMed  Google Scholar 

  28. Hashemi M, Eskandari-Nasab E, Fazaeli A, et al. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTT1, GSTM1, and GSTP1) and susceptibility to nonalcoholic fatty liver disease in Zahedan. Southeast Iran. DNA Cell Biol. 2012;31(5):672–7.

    Article  CAS  Google Scholar 

  29. Meng F, Song H, Luo C, et al. Correlation of LAPTM4B polymorphisms with cervical carcinoma. Cancer. 2011;117(12):2652–8.

    Article  CAS  PubMed  Google Scholar 

  30. Wang B, Xu J, Zhou R, et al. Association of LAPTM4B gene polymorphism with nasopharyngeal carcinoma susceptibility in a Chinese population. Med Oncol. 2013;30(1):470.

    Article  PubMed  Google Scholar 

  31. Li C, Zhou Q, Wang Y, et al. Relationship between LAPTM4B gene polymorphism and susceptibility of lung cancer. Zhongguo Fei Ai Za Zhi. 2006;9(2):109–12.

    CAS  PubMed  Google Scholar 

  32. Wang S, Zhang Q. Association of lysosome associated protein transmembrane 4 beta gene polymorphism with the risk of pancreatic cancer. Chin J Cancer Res. 2010;22(4):291–5.

    Article  CAS  Google Scholar 

  33. Li Y, Zou L, Li Q, et al. Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med. 2010;16(2):214–8.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Li L, Wei XH, Pan YP, et al. LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3 K/AKT signaling. Oncogene. 2010;29(43):5785–95.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project was supported by research grant from Zahedan University of Medical Sciences. The authors thank all individuals who willingly participated the study.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

    Mohammad Hashemi

  2. Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

    Mohammad Hashemi, Sahadi Amininia, Mahboubeh Ebrahimi & Ebrahim Eskandari-Nasab

  3. Department of Internal Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

    Seyed Mehdi Hashemi & Javad Yousefi

  4. Genetic of Non Communicable Disease Research Center, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

    Mohsen Taheri

  5. Deparmtent of Human Anatomy and Cell Science, College of Medicine, Faculty of Health Science, Manitoba Institute of Child Health, University of Manitoba, Winnipeg, Canada

    Saeid Ghavami

Authors
  1. Mohammad Hashemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sahadi Amininia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahboubeh Ebrahimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seyed Mehdi Hashemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Javad Yousefi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ebrahim Eskandari-Nasab
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mohsen Taheri
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Saeid Ghavami
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohammad Hashemi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hashemi, M., Amininia, S., Ebrahimi, M. et al. Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population. Med Oncol 31, 111 (2014). https://doi.org/10.1007/s12032-014-0111-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0111-8

Keywords

Search

Navigation